Sana Biotechnology (SANA) IPO Opens 40% Higher, Trends Up

Today's IPO for Sana Biotechnology, Inc. (NASDAQ: SANA) opened for trading at $35 after pricing 23,500,000 shares of its common stock at a public offering price of $25.00 per share. Shares have since moved up to $36.73.

Morgan Stanley, Goldman Sachs & Co. LLC, J.P. Morgan and BofA Securities are acting as joint book-running managers for the offering.

Sana Biotechnology, Inc. is focused on creating and delivering engineered cells as medicines for patients. Sana shares a vision of repairing and controlling genes, replacing missing or damaged cells, and making its therapies broadly available to patients. Sana is more than 250 people working together to create an enduring company that changes how the world treats disease. Sana has operations in Seattle, Cambridge, and South San Francisco.

You May Also Be Interested In

• Aggreko files for proposed IPO
• flyExclusive names Brian P. Reid as chief commercial officer
• CoVolt Power files for proposed IPO